Symmetry Investments LP Reduces Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Symmetry Investments LP decreased its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 83.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,168 shares of the company’s stock after selling 6,014 shares during the period. Symmetry Investments LP’s holdings in HCA Healthcare were worth $316,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Atria Wealth Solutions Inc. raised its holdings in HCA Healthcare by 21.2% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 1,678 shares of the company’s stock valued at $413,000 after acquiring an additional 293 shares during the period. Van ECK Associates Corp purchased a new position in HCA Healthcare in the third quarter worth $744,000. Pathstone Family Office LLC grew its position in HCA Healthcare by 248.3% in the third quarter. Pathstone Family Office LLC now owns 6,520 shares of the company’s stock worth $1,606,000 after acquiring an additional 4,648 shares in the last quarter. HighTower Advisors LLC grew its position in HCA Healthcare by 30.1% in the third quarter. HighTower Advisors LLC now owns 31,681 shares of the company’s stock worth $7,706,000 after acquiring an additional 7,322 shares in the last quarter. Finally, Aptus Capital Advisors LLC purchased a new stake in HCA Healthcare during the third quarter valued at about $244,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of HCA Healthcare stock in a transaction on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at approximately $789,470.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now owns 1,576 shares in the company, valued at $520,474. The disclosure for this sale can be found here. Insiders have sold 13,617 shares of company stock worth $4,321,986 in the last three months. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock traded down $3.37 on Tuesday, hitting $337.89. The company had a trading volume of 12,241 shares, compared to its average volume of 1,071,164. The stock’s 50-day simple moving average is $319.67 and its 200 day simple moving average is $310.91. The stock has a market cap of $88.50 billion, a price-to-earnings ratio of 17.01, a P/E/G ratio of 1.56 and a beta of 1.69. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $342.28. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company’s revenue was up 11.2% compared to the same quarter last year. During the same quarter last year, the company posted $4.93 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.78%. HCA Healthcare’s payout ratio is 13.16%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. TD Cowen cut their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. JPMorgan Chase & Co. increased their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Barclays increased their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Finally, Oppenheimer increased their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $325.59.

View Our Latest Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.